Article Details

AnPac Bio Receives Additional Nasdaq Warning Regarding Listing Requirement | Genomeweb

Retrieved on: 2022-03-15 02:40:59

Tags for this article:

Click the tags to see associated articles and topics

AnPac Bio Receives Additional Nasdaq Warning Regarding Listing Requirement | Genomeweb. View article details on hiswai:

Excerpt

NEW YORK – AnPac Bio-Medical Science said on Monday that it has received notice from Nasdaq that it has not met the exchange's minimum bid price ...

Article found on: www.genomeweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up